Literature DB >> 10691156

Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome.

M E Griffin1, M Coffey, H Johnson, P Scanlon, M Foley, J Stronge, N M O'Meara, R G Firth.   

Abstract

AIMS: Gestational diabetes mellitus (GDM) is associated with adverse maternal and fetal outcome. Screening for GDM is therefore recommended but the best screening method remains controversial. This prospective, randomized study compared a risk factor-based screening programme with a universally based one.
METHODS: Subjects were randomized at booking to one of two groups: the risk factor group had a 3-h 100-g oral glucose tolerance test (OGTT) at 32 weeks if any risk factor for GDM was present; the universal group had a 50-g glucose challenge test performed and if their plasma glucose at 1 h was > or = 7.8 mmol/l, a formal 3-h 100-g OGTT was then performed.
RESULTS: Universal screening detected a prevalence of GDM of 2.7%, significantly more than the 1.45% detected in the risk factor screened group (P<0.03). Universal screening facilitated earlier diagnosis than risk factor screening - mean gestation 30 +/- 2.6 weeks vs. 33 +/- 3.7 weeks (P<0.05). A higher rate of spontaneous vaginal delivery at term, and lower rates of macrosomia, Caesarean section, prematurity, pre-eclampsia and admission to neonatal intensive care unit were observed in the universally screened, early diagnosis group.
CONCLUSIONS: Universal screening for GDM is superior to risk factor based screening-detecting more cases, facilitating early diagnosis and is associated with improved pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691156     DOI: 10.1046/j.1464-5491.2000.00214.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  43 in total

Review 1.  Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.

Authors:  Joanna Tieu; Andrew J McPhee; Caroline A Crowther; Philippa Middleton; Emily Shepherd
Journal:  Cochrane Database Syst Rev       Date:  2017-08-03

2.  Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.

Authors:  E P O'Sullivan; G Avalos; M O'Reilly; M C Dennedy; G Gaffney; F Dunne
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

3.  Early universal screening for gestational diabetes mellitus.

Authors:  Ramya Neelakandan; Prabhu Shankar Sethu
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 4.  Japanese Clinical Practice Guideline for Diabetes 2016.

Authors:  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki
Journal:  Diabetol Int       Date:  2018-03-27

5.  Gestational diabetes mellitus screening and outcomes.

Authors:  Hale Lebriz Aktün; Derya Uyan; Betül Yorgunlar; Mustafa Acet
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-03-01

Review 6.  Pharmacological Management of Gestational Diabetes Mellitus.

Authors:  Geetha Mukerji; Denice S Feig
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

7.  Managing diabetes during pregnancy. Guide for family physicians.

Authors:  Ian P Sempowski; R L Houlden
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

8.  Gestational diabetes: pathogenesis and consequences to mother and offspring.

Authors:  Risto Kaaja; Tapani Rönnemaa
Journal:  Rev Diabet Stud       Date:  2009-02-10

Review 9.  Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand.

Authors:  P Reddi Rani; Jasmina Begum
Journal:  J Clin Diagn Res       Date:  2016-04-01

10.  The possible role of epigenetics in gestational diabetes: cause, consequence, or both.

Authors:  J L Fernández-Morera; S Rodríguez-Rodero; E Menéndez-Torre; M F Fraga
Journal:  Obstet Gynecol Int       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.